The Global Remote Patient Monitoring Devices Market Size is anticipated to reach over USD 1,882.75 Million by 2025 according to a new research published by Polaris Market Research.
Remote patient monitoring technology comprises devices such as glucose meters, blood pressure monitoring system, and other portable devices that are used by patients at a remote location. Growing usage of smartphones and increasing the expansion of the smartphone applications that are linked to the monitoring devices further helps in transmitting and recording person’s health-related data to the healthcare suppliers or specialists.
The rise in the implementation rate of remote patient monitoring devices, increasing number of geriatric population, and growing incidence of patients suffering from different lifestyle diseases are the major factor boosting the global remote patient monitoring devices market. With the increasing development in wireless technology, such monitoring devices are used to remotely monitor the physical parameters of the person such as heart rate, blood pressure, blood glucose level, and provide proper treatment if necessary. However, the high cost associated with this device, stringent reimbursement guidelines and issues correlated with the government regulations are some of the factors anticipated to hinder the global market growth.
The global Remote Patient Monitoring Devices Market is segmented on the basis of product type, application, end user, and geography.
On the basis of product type, the global Remote Patient Monitoring Devices Market is segmented into Heart Rate Monitors, Heart Monitors, Blood Pressure Monitors, Sleep Apnea Monitors, Breath Monitors, Weight Monitors, Blood Glucose Monitors, Infusion Pumps, and Body Temperature Monitors. On the basis of product type, Heart rate monitor is estimated to dominate the product segment owing to growing global incidences of cardiovascular incidence. The increase in the number of people with cardiac diseases has led to the augmented use of such monitoring devices.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:
https://www.polarismarketresearch.com/industry-analysis/global-remote-patient-monitoring-devices-market/request-for-sample
On the basis of application, the global Remote Patient Monitoring Devices Market is segmented into Cancer Treatment, Cardiovascular Diseases Treatment, Diabetes Treatment, Sleep Disorder Treatment, Weight Management and Fitness Monitoring. In 2017, cardiovascular disease treatment is estimated to dominate the market growth majorly owing to the increasing incidences of cardiovascular diseases. On the basis of the end user, the global Remote Patient Monitoring Devices Market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare settings.
On the basis of region, the global Remote Patient Monitoring Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global Remote Patient Monitoring Devices Market. The dominance is majorly attributed to the increasing occurrences of chronic diseases, growing demand for wireless and portable systems, increased level of healthcare spending, growing number of geriatric population, and favorable reimbursement scenarios in this region. However, Asia Pacific is expected to dominate the global Remote Patient Monitoring Devices Market during the forecast. Rising disposable income, high presence of untapped market opportunities primarily in developing economies, advancement in technology, supportive government initiatives are some of the factors expected to significantly boost the Remote Patient Monitoring Devices Market in the Asia Pacific.
Some major key players in global Remote Patient Monitoring Devices Market include Hoffmann-La Roche Ltd., AMD Global Telemedicine, Honeywell International Inc., Omron Healthcare, Smiths Medical, Medtronic among others. The object of the key market players is to deliver better chronic care administration while keeping the cost low. In addition, the companies are concentrating on producing easy-to-use monitoring devices that can aid patients to accomplish conditions including diabetes or heart diseases better by avoiding costly medical processes.
Request For Discount Price: https://www.polarismarketresearch.com/industry-analysis/global-remote-patient-monitoring-devices-market/request-for-discount-pricing
The Global Remote Patient Monitoring Devices Market Size is anticipated to reach over USD 1,882.75 Million by 2025 according to a new research published by Polaris Market Research.
Growing usage of smartphones and increasing the expansion of the smartphone applications that are linked to the monitoring devices further helps in transmitting and recording person’s health-related data to the healthcare suppliers or specialists.
However, the high cost associated with this device, stringent reimbursement guidelines and issues correlated with the government regulations are some of the factors anticipated to hinder the global market growth.
The global Remote Patient Monitoring Devices Market is segmented on the basis of product type, application, end user, and geography.
On the basis of product type, the global Remote Patient Monitoring Devices Market is segmented into Heart Rate Monitors, Heart Monitors, Blood Pressure Monitors, Sleep Apnea Monitors, Breath Monitors, Weight Monitors, Blood Glucose Monitors, Infusion Pumps, and Body Temperature Monitors.
In 2017, cardiovascular disease treatment is estimated to dominate the market growth majorly owing to the increasing incidences of cardiovascular diseases.
Autoinjectors are easy-to-handle and cost-effective medical devices that can be used by patients, caregivers, and even untrained personnel to deliver a dose of a particular drug.
Autoinjectors are used by patients to manage autoimmune diseases and chronic diseases.
They are used for a wide range of indications such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global Autoinjectors Market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.Use of autoinjectors in the treatment of rheumatoid arthritis drives the global autoinjectors marketRheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease that affects connective tissues.
It causes joints to swell and can result in pain, stiffness, and progressive loss of function.
According to the CDC, an estimated 43.7 million adults (22.7% of the total population) in the US annually are affected by some form of arthritis, RA, gout, lupus, or fibromyalgia.What Drives the Market?1.
Growing prevalence of targeted therapies2.
Cardiac Pacemaker Market OverviewGlobal cardiac pacemaker market has been expanding with the rising burden of cardiac diseases and increasing need for cardiac rhythm management.
However, older people are more active now than they ever used to be and activities like swimming, jogging and riding bikes to stay fit are activities most people above the age of 50 indulge in and are recommended to pursue by doctors.
However, disorders like cardiac arrhythmia can pose a significant hindrance to such activities and therefore more people are turning to cardiac implants like pacemakers to live a more active life.
Lifestyle diseases that are leading to increased cardiac disorders and increased expenditure for better health are factors adding impetus to North America cardiac pacemaker market.Europe cardiac pacemaker market is anticipated to account for the second largest revenue share due to increased government spending on enhancing the healthcare sector.
Research and development activities seeking better and more efficient solution to cardiac disorders is expected to augment market growth in the region.With emerging economies like China and India investing in healthcare infrastructure improvement, APAC region is slated to witness the fastest growing cardiac pacemaker market.
Also, medical tourism in Asian countries has been on the rise which has led to increased infrastructure development for medical centers and in turn led to significant growth in the cardiac pacemaker market.The MEA cardiac pacemaker market is expected to record slower growth due to lack of infrastructure and economic backwardness of the region.Cardiac Pacemaker Market Competitive Insight:There are several significant players in the cardiac pacemaker market such as Medtronic, BIOTRONIK, Boston Scientific Corporation, Abbott, MEDICO S.p.A., SORIN Group, LEPU MEDICAL, OSCOR Inc. etc.
Diagnostic Electrocardiograph Market Analysis The global diagnostic electrocardiograph market is likely to touch USD 10,487.24 million at a 6.72% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR).
Diagnostic electrocardiograph, simply put, is a test that is utilized to detect electrical signals which the heart produces each time it beats.
Download Sample (90 Pages PDF) Report For Free: To Know the Impact of COVID-19 on this Industry: https://www.marketresearchfuture.com/sample_request/8787Various factors are adding to the global diagnostic electrocardiograph market growth.
Such factors, according to the new MRFR report, include increasing expenditure by market players in research and development to create novel ECG devices, technological advances in wearable devices and wireless monitoring, and an increase in the rate of lifestyle diseases.
Additional factors adding market growth include the developing healthcare infrastructure, increasing geriatric population, and rising cases of cardiovascular diseases.
On the contrary, irregular reimbursement policies, uncertainty in economic circumstances and market saturation, and scarcity of skilled professionals are factors that may limit the diagnostic electrocardiograph market growth over the forecast periodDiagnostic Electrocardiograph Market SegmentationThe MRFR report offers an inclusive segmental analysis of the global Diagnostic Electrocardiograph (ECG) Market report based on end user, product type, and lead type.
Aug 09, 2019 (AB Digital via COMTEX) -- Market Trends
The global Cardiac Rehabilitation Devices Market is projected to reach over USD 2,839.9 million by 2023 at 6.2% CAGR during the review period of 2018 to 2023.
Cardiac rehabilitation is a medically managed program designed to improve cardiovascular health.
The rising prevalence of cardiac diseases, adoption of an unhealthy lifestyle and increasing geriatric population are driving the growth of the global cardiac rehabilitation devices market.
However, the factor such as the high cost of cardiac rehabilitation devices and stringent government regulations hinders market growth.
Cardiac Rehabilitation Devices Market Leading Companies:
